Status:
COMPLETED
Antiphospholipid Syndrome Collaborative Registry (APSCORE)
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Antiphospholipid Syndrome
Eligibility:
All Genders
Brief Summary
Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against th...
Detailed Description
Registry participants will have a blood sample drawn and will be interviewed about their medical histories. Participants will be asked to return for a follow-up visit after two years. Clinical, demogr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Antiphospholipid antibodies with or without associated clinical manifestations
Exclusion
Key Trial Info
Start Date :
April 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
860 Patients enrolled
Trial Details
Trial ID
NCT00076713
Start Date
April 1 2000
End Date
April 1 2007
Last Update
February 12 2013
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Morehouse School of Medicine
Atlanta, Georgia, United States, 30310
2
Johns Hopkins University
Baltimore, Maryland, United States, 21205
3
Hospital for Special Surgery, Weill-Cornell University Medical Center
New York, New York, United States, 10021
4
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599